¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Agents affecting calcification"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® calcification ÇÑ±Û ¼®È¸È­
¼³¸í   
  Á¶Á÷ ³»¿¡ Ä®½·ÀÇ Ä§ÂøÀ¸·Î °æÈ­µÇ´Â Çö»ó. Ç÷¾×À̳ª Á¶Á÷¾× ÁßÀÇ Ä®½·ÀÌ ¼¼Æ÷»çÀÌ¿¡ Ä§ÂøÇϴ °ÍÀ» ¸»ÇÑ´Ù. »ý¸®ÀûÀΠ¼®È¸È­·Î¼­ Ä¡¾Æ³ª »ÀÇü¼ºÀÌ ÀÖÀ¸¸ç ¼¼Æ÷°£ ±âÁú¼¶À¯ÀÇ ÁÖº¯ºÎ¿¡ Ä§ÂøµÈ ¼®È¸¿°¿¡ ÀÇÇØ¼­ °æÁ¶Á÷ÀÌ Çü¼ºµÈ´Ù. »ó¾ÆÁú, ½Ã¸àÆ®Áú, »À´Â Á¶Á÷ÇÐÀûÀ¸·Î´Â °áÇÕÁ¶Á÷À̸ç, Ç³ºÎÇÑ ±âÁú°ú °¢Á¾ ±½±âÀÇ ¾Æ±³Áú¼¶À¯°¡ Á¾È¾À¸·Î ´Þ·Á¼­ °íµµ·Î ¹ß´ÞÇÑ ¼¶À¯±¸Á¶¸¦ ÀÌ·é´Ù. ¼¶À¯¿¡ ¿¬Çؼ­ ¾ÆÆÄŸÀÌÆ®ÀÇ ¹Ì¼¼°áÁ¤ÀÌ Ä§ÂøÇØ¼­ ±×°ÍÀÌ ¼ºÀåÇÏ¿© ¼®È¸È­Á¶Á÷ÀÌ ¸¸µé¾îÁø´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcification
    ¼®È¸È­
  • dystrophic calcification
    ºñÁ¤»óÁ¶Á÷¼®È¸È­
  • mitral annular calcification
    ½Â¸ðÆÇ°í¸®¼®È¸È­
  • metastatic calcification
    ÀüÀ̼®È¸È­
  • pathologic calcification
    º´Àû¼®È¸È­
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcification
    ¼®È¸È­
  • mitral annular calcification
    ½Â¸ðÆÇ°í¸®¼®È¸È­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcification
    ¼®È¸È­
  • dystrophic calcification
    ºñÁ¤»óÁ¶Á÷¼®È¸È­
  • eggshell calcification
    ´Þ°¿²®Áú¼®È¸È­
  • metastatic calcification
    ÀüÀ̼®È¸È­
  • pathologic calcification
    º´Àû¼®È¸È­
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • psychological factors affecting medical condition
    ÀÇÇÐÀû»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • psychological factors affecting physical condition
    ½Åü»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • Chemosensitizing agents
    È­ÇÐÀû °¨°¢Á¦
  • H2 recepor blocking agents, for ulcers
    H2¼ö¿ëüÂ÷´ÜÁ¦(â¥é»ô÷ó´Ó¨ð¥)
  • aortic valve,bicuspid calcification
    ÀÌÆÇ ¼®È¸È­(ì£÷ûà´üéûù)
  • health care agents
    °Ç°­°ü¸®¿ä¿ø(ÊÙËíËô), °Ç°­°ü¸®±â±¸.
  • immunosuppressive agents
    ¸é¿ª¾ïÁ¦ÀÎÀÚ(¡­åäð¤ì×í­)
  • pineal calcification
    ¼Û°úü¼®È¸È­(áæÍýô÷à´üéûù).
  • pineal calcification
    ¼Û°úü¼®È¸È­(áæÍýô÷à´üéûù)
  • punctated calcification
    Á¡»ó ¼®È¸È­
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • psychological factors affecting medical condition
    ÀÇÇÐÀû»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • psychological factors affecting physical condition
    ½Åü»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • biologic agents
    »ý¹°ÇÐÀûÁ¦Á¦
  • eaton agents
    ÀÌÆ° º´¿øÃ¼
  • health care agents
    °Ç°­°ü¸®¿ä¿ø(ÊÙËíËô), °Ç°­°ü¸®±â±¸.
  • immunosuppressive agents
    ¸é¿ª¾ïÁ¦ÀÎÀÚ(¡­åäð¤ì×í­)
  • law for control of poisonous and powerful agents
    µ¶±Ø¹°Ãëü¹ý(ËÄË»ËŅ̬̃ ËÑ).
  • oral hypoglycemic agents
    °æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
  • oral hypoglycemic agents
    °æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
  • proteolytic agents
    ´Ü¹éºÐÇØÁ¦(¡­ÝÂú°ð¥).
  • skin protective agents
    ÇǺκ¸È£Á¦.
  • skin test agents
    ÇǺιÝÀÀ¾à(ù«Ý±Úãëëå·).
  • spermicidal agents
    »ìÁ¤Á¦(߯ïñð¥).
  • aortic valve,bicuspid calcification
    ÀÌÆÇ ¼®È¸È­(ì£÷ûà´üéûù)
  • calcification
    ¼®È¸È­
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Retention with calcification
    ¼®È¸ÀÜ·ù
    [¿¾ ¿ë¾î] ¼®È¸È­ÀÜ·ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • psychotropic agents
    Á¤½ÅÀÛ¿ë¾à(ïñãêíÂéÄå·)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcification
    ¼®È¸È­
  • clustered calcification
    ±ºÁý¼º¼®È¸È­
  • coarse calcification
    °ÅÄ£¼®È¸È­
  • egg shell calcification
    °è¶õ²®Áú¾ç¼®È¸È­
  • pathologic calcification
    º´Àû¼®È¸È­
  • pericardial calcification
    ½É¸·¼®È¸Ä§Âø
  • pineal calcification
    ¼Û°úü¼®È¸È­
  • punctate calcification
    Á¡»ó¼®È¸È­
  • soft tissue calcification
    ¿¬Á¶Á÷¼®È¸È­
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OHA Oral Hypoglycemic Agents
CTA Canadian Tuberculosis Association; chemotactic activity; chromotropic acid; Committee on Thrombolyti...
ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy
NAHPA National Association of Hospital Purchasing Agents
OHA oral hypoglycemic agents
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BGC Basal ganglia calcification
CAC Coronary artery calcification
MAC Mitral annular calcification
MAC Mitral annulus calcification
PC pineal calcification
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Y54.7
    Agents affecting calcification
    ¼®È¸È­¿¡ ÀÛ¿ëÇÏ´Â Á¦Á¦
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • affecting multiple system
    ´Ù¹ß¼º °èÅëÀ» ħ¹üÇÑ
  • basal ganglion calcification syndrome
    ±âÀú ½Å°æÀý ¼®È¸È­ ÁõÈıº
  • calcification
    ¼®È¸È­, Ä®½· Ä§Âø
    Àå±â Á¶Á÷ÀÌ Ä®½·¿°ÀÇ ÃàÀûÀ¸·Î ´Ü´ÜÇØ Áö´Â °úÁ¤.
  • calcification stage
    ¼®È¸È­±â
  • coarse calcification
    °ÅÄ£ ¼®È¸È­
  • dental calcification age
    Ä¡¾ÆÀÇ ¼®È¸È­ ¿¬·É
    Ä¡¾Æ°¡ ¼®È¸È­µÇ±â ½ÃÀÛÇØ¼­ºÎÅÍ ÇöÀç±îÁöÀÇ ½Ã°£.
  • dystrophic calcification
    ÀÌ¿µ¾ç¼º ¼®È¸È­
  • dystrophic pulp calcification
    ÀÌ¿µ¾ç¼º Ä¡¼ö ¼®È¸È­
    ±«»ç Ä¡¼ö Á¶Á÷¿¡¼­ ¹ß»ýÇÏ´Â °ÍÀ¸·Î ´ë°³ ¹«Áõ»óÀÌ´Ù. ¿Ïº®ÇÑ Ä¡±Ù´Ü ¼ºÇü¼ú ½ÃÇà ÀÌÀü¿¡ µÐÇÑ ¿Ü»óÀ» ¹Þ´Â °æ¿ì ¿­·ÁÁ® ÀÖ´Â Ä¡±Ù´Ü¿¡ ÀÇÇÑ Ç÷·ù È®»ê°ú ±«»ç Á¶Á÷ÀÇ ¼®È¸È­·Î ÀÎÇØ ¹ß»ý °¡´ÉÇÏ´Ù. µ¿Åë, Ä¡±Ù´Ü ÁÖÀ§ÀÇ ¹æ»ç¼± Åõ°ú»ó ¶Ç´Â ´Ù¸¥ ¿°Áõ¼º Áõ»ó Á¸Àç ½Ã¿¡´Â Ä¡¾Æ ±Ù°üÄ¡·á°¡ ÇÊ¿äÇÏ´Ù. Ä¡¾ÆÀÇ °ËÀº º¯»ö À¯¹ß ½Ã¿¡´Â ½É¹Ì¼º ¼öº¹¹°ÀÌ ÇÊ¿äÇÏ´Ù.
  • egg shell calcification
    °è¶õ ²®Áú¾ç ¼®È¸È­
  • lymphnode calcification
    ¸²ÇÁÀý, ¼®È¸È­
  • pericardial calcification
    ½É¸· ¼®È¸ Ä§Âø
  • pineal calcification
    ¼Û°úü ¼®È¸È­
  • pulp calcification
    Ä¡¼ö ¼®È¸Áõ, Ä¡¼ö ¼®È¸È­
    Ä¡¼ö Á¶Á÷ ºÎÀ§°¡ ¼®È¸È­µÈ ¹°Áú·Î ´ëüµÇ´Â °Í.
  • punctate calcification
    Á¡»ó ¼®È¸È­
  • zone of temporary calcification
    ÀϽÃÀû ¼®È¸È­´ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adrenal calcification <radiology> Haemorrhage, cyst, Addison's disease (e.g., TB, histo), neoplasm, pheochromocytoma, adrenal cortical adenoma/carcinoma, adrenal choristoma (myelolipoma), metastatic melanoma, Wolman disease
(12 Dec 1998)
basal ganglia calcification <radiology> Idiopathic: normal variant (50%), abnormal calcium metabolism, hyperparathyroidism, hypo-, pseudohypo-, and pseudo-pseudohypoparathyroidism, ToRCHS infection (especially CMV, toxo), tuberous sclerosis, Cockayne syndrome, Fahr syndrome (ferrocalcinosis), lipoid proteinosis (hyalinosis cutis)
(12 Dec 1998)
bladder calcification <radiology> Schistosomiasis (bilharziasis), major cause worldwide, 50% have calcification, can cause squamous cell carcinoma, TB and other infections, radiation cystitis, calculi, bladder neoplasms, transitional cell carcinoma, squamous cell carcinoma, leiomyosarcoma, haemangioma, neuroblastoma, osteosarcoma
(12 Dec 1998)
calcification <biochemistry> The process by which organic tissue becomes hardened by a deposit of calcium salts within its substance.
Origin: L. Facere = to make.
(21 Mar 1998)
calcification lines of Retzius Incremental line's of rhythmic deposition of successive layers of enamel matrix during development.
Synonym: lines of Retzius.
(05 Mar 2000)
calcification, physiologic Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.
(12 Dec 1998)
pathologic calcification Calcification occurring in excretory or secretory passages as calculi, and in tissues other than bone and teeth.
(05 Mar 2000)
renal calcification <radiology> Nephrolithiasis, nephrocalcinosis, medullary (more common), cortical, neoplastic or inflammatory mass, renal cell carcinoma, XGP, tuberculosis
(12 Dec 1998)
metastatic calcification Calcification occurring in nonosseous, viable tissue (i.e., tissue that is not degenerated or necrotic), as in the stomach, lungs, and kidneys (and rarely in other sites); the cells of these organs secrete acid materials, and, under certain conditions in instances of hypercalcaemia, the alteration in pH seems to cause precipitation of calcium salts in these sites.
(05 Mar 2000)
gyral brain calcification <radiology> Sturge-Weber-Dimitri syndrome, treated CNS lymphoma, post-meningoencephalitis, brain tumour (oligodendroglioma)
(12 Dec 1998)
physiological intracranial calcification <radiology> Pineal gland, habenular commisure, choroid plexus, dura, pacchionian bodies, basal ganglia and dentate nucleus
(12 Dec 1998)
Monckeberg's calcification Arterial sclerosis involving the peripheral arteries, especially of the legs of older people, with deposition of calcium in the medial coat (pipestem arteries) but with little or no encroachment on the lumen.
Synonym: medial arteriosclerosis, Monckeberg's calcification, Monckeberg's degeneration, Monckeberg's medial calcification, Monckeberg's sclerosis.
(05 Mar 2000)
Monckeberg's medial calcification Arterial sclerosis involving the peripheral arteries, especially of the legs of older people, with deposition of calcium in the medial coat (pipestem arteries) but with little or no encroachment on the lumen.
Synonym: medial arteriosclerosis, Monckeberg's calcification, Monckeberg's degeneration, Monckeberg's medial calcification, Monckeberg's sclerosis.
(05 Mar 2000)
pineal gland calcification <radiology> Visible on plain skull film (33-76% in adults), seen more frequently on CT, rare in kids less than 6 y.o. (presence suggests neoplasm), usually in the form of a cluster of amorphous, irregular densities, may be solitary, the size of calcification: usually 3-5 mm, if greater than 1 cm, suspect pinealoma, AV malformation, etc. See: physiological intracranial calcifications
(12 Dec 1998)
coronary artery calcification <radiology> In setting of chest pain, upto 94% will have significant coronary artery calcification
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcification
    ¼®È¸È­;¼®È¸¼º ¹°ÁúÀÇ Ä§Àü
  • affecting
    °¨µ¿½ÃŰ´Â
  • affecting
    °¨µ¿½ÃŰ´Â;°¨µ¿ÀûÀÎ;°¡·ÃÇÑ;¾Öó·Î¿î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á